BIIB
Biogen Inc
NASDAQ: BIIB · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$194.38
+6.00% today
Updated 2026-04-29
Market cap
$28.53B
P/E ratio
20.92
P/S ratio
2.88x
EPS (TTM)
$9.29
Dividend yield
—
52W range
$115 – $202
Volume
1.1M
Biogen Inc (BIIB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.68B | $3.17B | $4.10B | $4.38B | $4.72B | $5.05B | $5.51B | $6.93B | $9.70B | $10.76B | $11.45B | $12.27B | $13.45B | $14.38B | $13.44B | $10.98B | $10.17B | $9.84B | $9.68B | $9.81B |
| Revenue growth (YoY) | — | +18.2% | +29.2% | +6.8% | +7.7% | +7.0% | +9.2% | +25.7% | +40.0% | +10.9% | +6.4% | +7.2% | +9.6% | +6.9% | -6.5% | -18.3% | -7.4% | -3.3% | -1.6% | +1.4% |
| Cost of revenue | $274.38M | $335.19M | $401.99M | $382.10M | $400.26M | $466.78M | $545.49M | $857.70M | $1.17B | $1.24B | $1.43B | $1.63B | $1.82B | $1.96B | $1.81B | $2.11B | $2.28B | $2.53B | $2.31B | $2.90B |
| Gross profit | $2.41B | $2.84B | $3.70B | $4.00B | $4.32B | $4.58B | $4.97B | $6.07B | $8.53B | $9.52B | $10.02B | $10.64B | $11.64B | $12.42B | $11.64B | $8.87B | $7.90B | $7.30B | $7.37B | $6.91B |
| Gross margin | 89.8% | 89.4% | 90.2% | 91.3% | 91.5% | 90.8% | 90.1% | 87.6% | 87.9% | 88.5% | 87.5% | 86.7% | 86.5% | 86.4% | 86.6% | 80.8% | 77.6% | 74.2% | 76.1% | 70.5% |
| R&D | $718.39M | $925.16M | $1.07B | $1.28B | $1.25B | $1.22B | $1.38B | $1.46B | $1.89B | $2.01B | $1.97B | $2.37B | $2.71B | $2.77B | $4.53B | $3.40B | $2.60B | $2.70B | $2.49B | $1.95B |
| SG&A | $685.07M | $776.10M | $925.30M | $1.13B | $1.29B | $1.37B | $1.22B | $1.64B | $2.14B | $2.00B | $1.84B | $1.86B | $2.02B | $2.28B | $2.40B | $2.58B | $2.35B | $2.43B | $2.32B | $2.43B |
| Operating income | $440.02M | $779.77M | $1.21B | $1.30B | $1.25B | $1.72B | $1.84B | $2.52B | $3.97B | $4.89B | $5.15B | $5.35B | $5.89B | $7.04B | $4.59B | $2.79B | $2.89B | $2.10B | $2.49B | $1.88B |
| Operating margin | 16.4% | 24.6% | 29.6% | 29.6% | 26.5% | 34.2% | 33.3% | 36.3% | 40.9% | 45.4% | 45.0% | 43.6% | 43.8% | 49.0% | 34.2% | 25.4% | 28.4% | 21.3% | 25.7% | 19.1% |
| EBITDA | $868.93M | $1.33B | $1.67B | $1.80B | $1.62B | $2.10B | $2.20B | $3.02B | $4.60B | $5.62B | $6.35B | $6.61B | $7.01B | $7.74B | $5.11B | $3.92B | $3.54B | $2.38B | $3.00B | $3.10B |
| EBITDA margin | 32.4% | 42.0% | 40.8% | 41.0% | 34.4% | 41.7% | 40.0% | 43.6% | 47.5% | 52.2% | 55.4% | 53.8% | 52.1% | 53.8% | 38.0% | 35.7% | 34.8% | 24.2% | 31.0% | 31.6% |
| EBIT | $493.06M | $951.10M | $1.21B | $1.37B | $1.27B | $1.74B | $1.84B | $2.49B | $3.97B | $5.01B | $5.71B | $5.89B | $6.36B | $7.28B | $4.65B | $3.44B | $3.02B | $1.88B | $2.32B | $2.17B |
| Interest expense | $871000.00 | $40.50M | $52.00M | $35.80M | $36.10M | $33.00M | $36.50M | $31.90M | $29.50M | $95.50M | $260.00M | $250.80M | $200.60M | $187.40M | $222.50M | $253.60M | $246.60M | $246.90M | $250.30M | $246.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $217.51M | $638.17M | $783.17M | $970.13M | $1.01B | $1.23B | $1.38B | $1.86B | $2.93B | $3.55B | $3.70B | $2.54B | $4.43B | $5.89B | $4.00B | $1.56B | $3.05B | $1.16B | $1.63B | $1.29B |
| Net income growth (YoY) | — | +193.4% | +22.7% | +23.9% | +3.6% | +22.8% | +11.8% | +34.9% | +57.6% | +20.9% | +4.4% | -31.4% | +74.5% | +32.9% | -32.1% | -61.1% | +95.8% | -61.9% | +40.6% | -20.8% |
| Profit margin | 8.1% | 20.1% | 19.1% | 22.2% | 21.3% | 24.5% | 25.0% | 26.9% | 30.2% | 33.0% | 32.3% | 20.7% | 32.9% | 41.0% | 29.8% | 14.2% | 29.9% | 11.8% | 16.9% | 13.2% |